Home » Toronto Stock Exchange Reviewing GeneNews' Eligibility for Continued Listing

Toronto Stock Exchange Reviewing GeneNews' Eligibility for Continued Listing

Jan 19, 2016
|
staff reporter

NEW YORK (GenomeWeb) – Canadian molecular diagnostics company GeneNews announced today that it has received notice that the Toronto Stock Exchange is reviewing its eligibility to remain listed on the TSX. GeneNews has 60 days to show that it is in compliance with the continued listing requirements of the exchange.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

All About the Proteins

The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.

Lab Space and a Dream

Bloomberg profiles IndieBio, a startup incubator for the life sciences.

"Must Stop"

In an editorial, Nature calls for the end to the exploitation of foreign postdocs.

This Week in Nucleic Acids Research

In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.

What's Popular?

In Business News

  1. Illumina Ventures Leads €16M Series A Investment in Digital PCR Firm Stilla Technologies

  2. BD, Cellular Research Sue 10x Genomics for Infringing Single-Cell Analysis Patents

  3. Two Pore Guys Receive $2.8M TB Dx Grant From Bill & Melinda Gates Foundation

  4. Guardant Health Q3 Revenues Jump 95 Percent

  5. NanoString, Silicon Valley Bank Amend Loan Agreement

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.